Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins

Brain Research

Volumn 1033, Issue 2, 2005, Pages 143-150

  Kotake, Yaichiro ^a,b   Taguchi, Ryota ^a   Okuda, Katsuhiro ^a   Sekiya, Yoko ^a   Tasaki, Yoshikazu ^c   Hirobe, Masaaki ^c   Ohta, Shigeru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Complex I; Neuroprotective; Parkinson's disease; Primary mesencephalic culture; Tetrahydroisoquinoline

Indexed keywords

1 BENZYL 1,2,3,4 TETRAHYDROISOQUINOLINE; 1 METHYL 1,2,3,4 TETRAHYDROISOQUINOLINE; 1 METHYL 4 PHENYLPYRIDINIUM; BRAIN AMINE; DOPAMINE RECEPTOR; ISOQUINOLINE DERIVATIVE; NEUROTOXIN; OXIDOPAMINE; ROTENONE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN NERVE CELL; CELL CULTURE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG STRUCTURE; FETUS; MALE; MESENCEPHALON; MITOCHONDRIAL RESPIRATION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PREGNANCY; RATS; RATS, WISTAR; ROTENONE; TETRAHYDROISOQUINOLINES;

EID: 13244275007     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.11.019     Document Type: Article

References (38)

1. K. Abe, K. Taguchi, T. Wasai, I. Utsunomiya, T. Shinohara, T. Miyatake, and T. Sano Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4- tetrahydroisoquinolines on a mouse model of Parkinson's disease Brain Res. Bull. 56 2001 55 60
2. L. Antkiewicz-Michaluk, J. Wardas, J. Michaluk, I. Romaska, A. Bojarski, and J. Vetulani Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone Int. J. Neuropsychopharmacol. 7 2004 155 163
3. A. Ayala, J. Parrado, J. Cano, and A. Machado Reduction of l-methyl-l,2,3,4-tetrahydroisoquinoline level in substantia nigra of the aged rat Brain Res. 638 1994 334 336
4. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
5. W. Billard, V. Ruperto, G. Crosby, L.C. Iorio, and A. Barnett Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum Life Sci. 35 1984 1885 1893
6. Y. Hatefi Preparation and properties of NADH:ubiquinone oxidoreductase (complex I). EC 1.6.5.3 S. Fleischers L. Packer Methods in Enzymology vol. 53 1978 Academic Press New York 11 14
7. N. Hattori, M. Tanaka, T. Ozawa, and Y. Mizuno Immunological studies on complex I, II, III, and IV of mitochondria in Parkinson's disease Ann. Neurol. 30 1991 563 571
8. N. Hattori, H. Yoshino, M. Tanaka, H. Suzuki, and Y. Mizuno Genotype in the 24 kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson's disease Genomics 49 1998 52 58
9. K. Igarashi, Y. Sugiyama, F. Kasuya, K. Saiki, T. Yamakawa, and S. Ohta Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring J. Chromotogr., B, Biomed. Sci. Appl. 731 1999 53 58
10. H. Kawai, Y. Kotake, and S. Ohta Dopamine transporter and catechol-O-methyltransferase activities are required for the toxicity of l-(3′,4′-dihydroxybenzyl)-l,2,3,4-tetrahydroisoquinoline Chem. Res. Toxicol. 13 2001 1294 1301
11. M. Kohno, S. Ohta, and M. Hirobe Tetrahydroisoquinoline and l-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain Biochem. Biophys. Res. Commun. 140 1986 448 454
12. + analogs acting on mitochondria and inducing neuro-degeneration Curr. Med. Chem. 10 2003 2507 2516
13. Y. Kotake, Y. Tasaki, Y. Makino, S. Ohta, and M. Hirobe l-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF J. Neurochem. 65 1995 2633 2638
14. Y. Kotake, M. Yoshida, M. Ogawa, Y. Tasaki, M. Hirobe, and S. Ohta Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate Neurosci. Lett. 217 1996 69 71
15. Y. Kotake, Y. Tasaki, M. Hirobe, and S. Ohta Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4- tetrahydroisoquinoline in mice: in vivo and in vitro studies Brain Res. 787 1998 341 343
16. Y. Kotake, S. Ohta, I. Kanazawa, and M. Sakurai Neurotoxicity of an endogenous brain amine, l-benzyl-1,2,3,4-tetrahydroisoquinoline in organotypic slice co-culture of mesencephalon and striatum Neuroscience 117 2003 63 70
17. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
18. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J. Biol. Chem. 193 1951 265 275
19. + analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease Neurology 45 1995 2240 2245
20. K.S. McNaught, P.A. Carrupt, C. Altomare, S. Cellamare, A. Carotti, B. Testa, P. Jenner, and C.D. Marsden Isoquinoline derivatives as endogenous neurotoxins in the etiology of Parkinson's disease Biochem. Pharmacol. 56 1998 921 933
21. Y. Mizuno, H. Yoshino, S. Ikebe, N. Hattori, T. Kobayashi, S. Shimoda-Matsubayashi, H. Matsumine, and T. Kondo Mitochondrial dysfunction in Parkinson's disease Ann. Neurol. 44 1998 S99 S109
22. N. Morikawa, M. Naoi, W. Maruyama, S. Ohta, Y. Kotake, H. Kawai, T. Niwa, P. Dostert, and Y. Mizuno Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes J. Neural Transm. 105 1998 677 688
23. T. Nagatsu Isoquinoline neurotoxins in the brain and Parkinson's disease Neurosci. Res. 29 1997 99 111
24. + cause nigrostriatal toxicity after substantia nigra injections in rats Brain Res. 675 1995 279 288
25. S. Ohta, M. Kohno, Y. Makino, O. Tachikawa, and M. Hirobe Tetrahydroisoquinoline and 1-methyltetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease Biomed. Res. 8 1987 453 456
26. K. Okuda, Y. Kotake, and S. Ohta Determination method of 1-methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-preventing substance, by radioimmunoassay Life Sci. 70 2002 2871 2883
27. W.D. Parker Jr., S.J. Boyson, and J.K. Parks Abnormalities of the electron transport chain in idiopathic Parkinson's disease Ann. Neurol. 26 1989 719 723
28. + J. Neurochem. 75 2000 65 71
29. 1 reductase (complex-I) deficiency in Parkinson's disease J. Neurochem. 55 1990 2142 2145
30. A. Storch, A. Kaftan, K. Burkhardt, and J. Schwarz 1-Methyl-6,7- dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism Brain Res. 855 2000 67 75
31. Y. Tasaki, Y. Makino, S. Ohta, and M. Hirobe l-Methyl-1,2,3,4- tetrahydroisoquinoline, decreasing in l-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities J. Neurochem. 57 1991 l940 1943
32. 3H] sulpiride to rat striatal preparations J. Pharm. Pharmacol. 31 1979 424 426
33. H. Thoenen, and J.P. Tranzer The pharmacology of 6-hydroxydopamine Annu. Rev. Pharmacol. 13 1973 169 180
34. K.F. Tipton, and T.P. Singer Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds J. Neurochem. 61 1993 1191 1206
35. U. Ungerstedt 6-Hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome Pharmacol. Ther., B 2 1976 37 40
36. S. Usuda, K. Nishikori, O. Noshiro, and H. Maeno Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4- methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity Psychopharmacology (Berl) 73 1981 l03 109
37. T. Yamakawa, and S. Ohta Isolation of 1-methyl-1,2,3,4- tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme Biochem. Biophys. Res. Commun. 236 1997 676 681
38. T. Yamakawa, Y. Kotake, M. Fujitani, H. Shintani, Y. Makino, and S. Ohta Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain Neurosci. Lett. 276 1999 68 70